✦ LIBER ✦

C.10.03 Neglected targets and future directions in the treatment of generalised anxiety

✍ Scribed by T. Dinan

Book ID: 118593259
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 70 KB
Volume: 16
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(06)70837-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future directions in the treatment of an

Future directions in the treatment of anxiety

✍ Robert M.A. Hirschfeld 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Tandospirone in the Treatment of General

Tandospirone in the Treatment of Generalised Anxiety Disorder and Mixed Anxiety-Depression

✍ K. Nishitsuji, H. To, Y. Murakami, K. Kodama, D. Kobayashi, T. Yamada, C. Kubo, 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 92 KB

Future directions in the treatment of am

Future directions in the treatment of amblyopia

✍ Emilio C Campos 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 18 KB

C.10.02 Generalised anxiety disorder: di

C.10.02 Generalised anxiety disorder: differential efficacy of anxiolytic treatments across the range of symptoms and clinical subgroups

✍ J. Boulenger 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Mexazolam and Alprazolam in the Treatmen

Mexazolam and Alprazolam in the Treatment of Generalised Anxiety Disorder

✍ Adriano Vaz-Serra, Maria Luisa Figueira, Alberto Bessa-Peixoto, Horácio Firmino, 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 174 KB

Future directions in the treatment of Pa

Future directions in the treatment of Parkinson's disease

✍ Anthony H.V. Schapira 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

The development of treatment for the symptoms of Parkinson's disease (PD) has been one of the most notable successes of neurology. Dopaminergic therapies in the form of levodopa, dopamine agonists, or monoamine oxidase B inhibitors significantly improve the characteristic motor symptoms of bradykine